Traders Currently Passing Around Disclosure in Taro Pharma 6-K from Fri. After the Close: Co., Two Senior Officers in Commercial Unit Received Grand Jury Subpoenas from DoJ, Antitrust Unit, Seeking Documents
Paul Quintaro